Baloxavir in Combination With Oseltamivir in Allogenic Bone Marrow Transplant Recipients With Influenza
Clinical trial NCT05170009 · TERMINATED
Trial details
- NCT number
- NCT05170009
- Sponsor
- Weill Medical College of Cornell University
- Status
- TERMINATED
- Phase
- Phase 2, Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2022-04-22
- Primary completion
- 2024-01-17
- Enrollment
- 2
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.